Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Seban, R.-D., Champion, L., Bellesoeur, A., Vincent-Salomon, A., Bidard, F.-C. Tags: Letters Source Type: research